Garzia; Raffaella
Patent Applications and Registrations
Patent applications and USPTO patent grants for Garzia; Raffaella.The latest application filed is for "optimised formulation of tobramycin for aerosolization".
- Garzia; Raffaella - Parma IT
| Patent | Date |
|---|---|
| Pharmaceutical aerosol composition Grant 8,420,058 - Lewis , et al. April 16, 2 | 2013-04-16 |
| Optimised Formulation Of Tobramycin For Aerosolization App 20120184502 - MALVOLTI; Chiara ; et al. | 2012-07-19 |
| Optimised formulation of tobramycin for aerosolization Grant 8,168,598 - Malvolti , et al. May 1, 2 | 2012-05-01 |
| Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining Grant 8,142,763 - Lewis , et al. March 27, 2 | 2012-03-27 |
| Optimised Formulation Of Tobramycin For Aerosolization App 20110212912 - Malvolti; Chiara ; et al. | 2011-09-01 |
| Optimised formulation of tobramycin for aerosolization Grant 7,939,502 - Malvolti , et al. May 10, 2 | 2011-05-10 |
| Pressurised Metered Dose Inhalers (mdi) App 20110100361 - LEWIS; David ; et al. | 2011-05-05 |
| Pressurised metered dose inhalers (MDI) Grant 7,740,463 - Lewis , et al. June 22, 2 | 2010-06-22 |
| Optimised Formulation Of Tobramycin For Aerosolization App 20100098642 - Malvolti; Chiara ; et al. | 2010-04-22 |
| Optimised formulation of tobramycin for aerosolization Grant 7,696,178 - Malvolti , et al. April 13, 2 | 2010-04-13 |
| Pharmaceutical Aerosol Composition App 20090311196 - LEWIS; David ; et al. | 2009-12-17 |
| Pharmaceutical aerosol composition Grant 7,601,336 - Lewis , et al. October 13, 2 | 2009-10-13 |
| Pressurised Metered Dose Inhalers (mdi) App 20080247965 - LEWIS; David ; et al. | 2008-10-09 |
| Pressurised Metered Dose Inhalers (mdi) App 20080115782 - LEWIS; David ; et al. | 2008-05-22 |
| Pressurised metered dose inhalers (MDI) Grant 7,347,199 - Lewis , et al. March 25, 2 | 2008-03-25 |
| Pressurised metered dose inhalers (MDI) Grant 7,223,381 - Lewis , et al. May 29, 2 | 2007-05-29 |
| Optimized formulation of tobramycin for aerosolization Grant 6,987,094 - Malvolti , et al. January 17, 2 | 2006-01-17 |
| Formulations of steroid solutions for inhalatory administration Grant 6,967,017 - Malvolti , et al. November 22, 2 | 2005-11-22 |
| Optimised formulation of tobramycin for aerosolization App 20050163722 - Malvolti, Chiara ; et al. | 2005-07-28 |
| Pressurised metered dose inhalers (MDI) App 20050142071 - Lewis, David ; et al. | 2005-06-30 |
| Pharmaceutical aerosol composition containing HFA 227 and HFA 134a App 20040184993 - Lewis, David ; et al. | 2004-09-23 |
| Optimised formulation of tobramycin for aerosolization App 20040186064 - Malvolti, Chiara ; et al. | 2004-09-23 |
| Pressurised metered dose inhalers (MDI) App 20040096399 - Lewis, David ; et al. | 2004-05-20 |
| Pharmaceutical aerosol composition App 20040062720 - Lewis, David ; et al. | 2004-04-01 |
| Pharmaceutical aerosol composition containing HFA 227 and HFA 134a Grant 6,713,047 - Lewis , et al. March 30, 2 | 2004-03-30 |
| Pharaceutical aerosol composition App 20030206870 - Lewis, David ; et al. | 2003-11-06 |
| Pharaceutical aerosol composition App 20030190287 - Lewis, David ; et al. | 2003-10-09 |
| Pressurised metered dose inhalers (MDI) App 20030089369 - Lewis, David ; et al. | 2003-05-15 |
| Pressurised metered dose inhalers (MDI) App 20030066525 - Lewis, David ; et al. | 2003-04-10 |
| Process for the preparation of suspensions of drug particles for inhalation delivery Grant 6,464,958 - Bernini , et al. October 15, 2 | 2002-10-15 |
| Pharmaceutical aerosol composition App 20010031244 - Lewis, David ; et al. | 2001-10-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 